
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SEC13 CRISPR/Cas9 KO Plasmid (m) | sc-431017 | 20 µg | $397.00 |
Sec13 encodes SEC13, a core component of the COPII coat complex that drives cargo selection and vesicle budding from endoplasmic reticulum exit sites to support ER-to-Golgi trafficking. Beyond secretory pathway function, SEC13 participates in nuclear pore complex architecture and contributes to regulation of cellular homeostasis through membrane trafficking–dependent control of protein localization and turnover. Disruption of SEC13-dependent transport can perturb proteostasis, stress signaling, and cell cycle coordination, making Sec13 a useful node for studying pathways that intersect secretion, membrane dynamics, and nuclear-cytoplasmic exchange. In mouse systems, Sec13 loss-of-function models are relevant for probing how trafficking and pore-associated processes influence development and disease-associated cellular phenotypes.
SEC13 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Sec13 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Sec13 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Sec13 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SEC13 protein expression.
This CRISPR knockout system enables efficient generation of Sec13-deficient cell models for investigation of SEC13 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.